Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers
نویسندگان
چکیده
منابع مشابه
Oculo-Visual Dysfunction in Parkinson’s Disease
This review describes the oculo-visual problems likely to be encountered in Parkinson's disease (PD) with special reference to three questions: (1) are there visual symptoms characteristic of the prodromal phase of PD, (2) is PD dementia associated with specific visual changes, and (3) can visual symptoms help in the differential diagnosis of the parkinsonian syndromes, viz. PD, progressive sup...
متن کاملElectrocardiographic abnormalities and their association with some serum biomarkers in lambs with foot and mouth disease
Little attention has been paid to the aspects of cardiac injury-related foot and mouth disease (FMD) in young animals. So, this research was conducted to evaluate the serum biomarkers and electrocardiographic (ECG) evidence of myocardial injury in the infected lambs with FMD. During an outbreak, 33 lambs with FMD and 11 healthy lambs were randomly enrolled. After blood sampling, ECGs were taken...
متن کاملCranial Nerve Abnormalities in Oculo-Auriculo-Vertebral Spectrum.
BACKGROUND AND PURPOSE Cranial nerve abnormalities might be observed in hemifacial microsomia and microtia (oculo-auriculo-vertebral spectrum), but the rate, features, and relationship with functional impairment or phenotype severity have not yet been defined. This study aimed at investigating absence/asymmetry, abnormal origin, morphology and course of cranial nerves, and presence/asymmetry of...
متن کاملMelatonin in Chagas' disease. Possible therapeutic value.
Chagas' disease is a severe health problem in Latin America, causing approximately 50 000 deaths a year, with approximately 18 million infected people. About 25-30% of the patients infected with Trypanosoma cruzi develop the chronic form of the disease. The protective response against T. cruzi depends on both innate and acquired immunity involving macrophages, natural killer cells, T and B lymp...
متن کاملMultimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities
Imaging biomarkers are frequently proposed as endpoints for clinical trials targeting brain amyloidosis in Alzheimer's disease (AD); however, the specific impact of amyloid-β (Aβ) aggregation on biomarker abnormalities remains elusive in AD. Using the McGill-R-Thy1-APP transgenic rat as a model of selective Aβ pathology, we characterized the longitudinal progression of abnormalities in biomarke...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Movement Disorders
سال: 2018
ISSN: 0885-3185
DOI: 10.1002/mds.27454